FinVector Competitors and Similar CompaniesClear all

FinVector's competitors and similar companies include Grindeks, Selonterra, Reneo Pharmaceuticals and Apic Bio.

	FinVector FinVector is a company engaged in the research and development of gene and cell therapies.	Grindeks Grindeks, a pharmaceutical company, engages in the research, development, manufacture, and sale of generics and active pharmaceutical ingredients.	Selonterra Selonterra is a company that develops therapeutics for Alzheimer's and Parkinson's diseases.	Reneo Pharmaceuticals Reneo Pharmaceuticals is a pharmaceutical company focused on the development of therapies for patients with genetic mitochondrial diseases.	Apic Bio Apic Bio is a gene therapy company developing novel treatment options for patients with rare genetic diseases.
Founding Date	Founding Date 2013	Founding Date 1991	Founding Date 2017	Founding Date 2018	Founding Date 2017
Type	Type Private	Type Private	Type Private	Type Subsidiary	Type Private
Tags	Tags Healthcare drug development genetics pharma therapy	Tags Healthcare drug development genetics pharma therapy	Tags Healthcare drug development genetics pharma therapy	Tags Healthcare drug development genetics pharma therapy	Tags Healthcare bioengineering drug development genetics pharma therapy
Locations	Locations Kuopio, FI HQ	Locations Rīga, LV HQ Yerevan, AM Bakı, AZ Minsk, BY Tallinn, EE Tbilisi, GE Almaty, KZ see more	Locations San Mateo, US HQ	Locations San Diego, US HQ Sandwich, GB Irvine, US	Locations Cambridge, US HQ Cambridge, US
Employees	Employees 338	Employees 1,505	Employees 3	Employees 46475% increase	Employees 6
Financial
Net income	Net income N/A	Net income €13.5m (FY, 2019)	Net income N/A	Net income ($59.5m) (FY, 2025)	Net income N/A
Funding
Total funding raised	Total funding raised N/A	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 145m	Total funding raised $ 51m